Frankie A. Holmes

Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer

Kathy D. Miller, Linnea Chap, Frankie A. Holmes et al. · Journal of Clinical Oncology · 2005 · 1.3K citations · Full text

THE IMPACT OF NATIONAL CANCER ACT

Frankie A. Holmes, Ronald S. Walters, Richard L. Theriault et al. · JNCI Journal of the National Cancer Institute · 1991 · 802 citations

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

Frankie A. Holmes, R S Walters, R. Theriault et al. · JNCI Journal of the National Cancer Institute · 1991 · 745 citations

Metastatic Breast Cancer, Oncology, Active Drug +14

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735

Stephen E. Jones, Frankie A. Holmes, Joyce O’Shaughnessy et al. · Journal of Clinical Oncology · 2009 · 584 citations

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10